Cerus (CERS) Finished Goods (2013 - 2021)

Cerus (CERS) posted Finished Goods of $24.5 million for Q2 2021, up 21.53% sequentially from $20.2 million in Q1 2021.

Cerus (CERS) Finished Goods (2013 - 2021) Analysis & Trends

Cerus has reported Finished Goods for 9 years, with the latest figure at $24.5 million in Q2 2021.

Quarterly Finished Goods changed N/A year-over-year to $24.5 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $24.5 million (changed N/A YoY) and the FY2020 annual result came in at $18.2 million, up 26.71% from the prior year.
Finished Goods rose to $24.5 million in Q2 2021 per CERS's latest filing, from $20.2 million in the prior quarter.
Over five years, Finished Goods peaked at $24.5 million in Q2 2021 and troughed at $8.2 million in Q2 2017.
A 5-year average of $13.3 million and a median of $11.4 million in 2019 frame the typical range for Finished Goods.
The sharpest annual moves came in 2018 and 2019: Finished Goods retreated 10.16% in 2018, then surged 60.35% in 2019.
Over 5 years, Finished Goods stood at $10.2 million in 2017, then grew by 3.01% to $10.5 million in 2018, then surged by 36.95% to $14.3 million in 2019, then rose by 26.71% to $18.2 million in 2020, then soared by 35.17% to $24.5 million in 2021.
According to Business Quant data, Finished Goods over the past three periods registered $24.5 million, $20.2 million, and $18.2 million for Q2 2021, Q1 2021, and Q4 2020 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Cerus	560.58 Mn	504.32 Mn	29.53 Mn

Download Data